Behavioral Health Business December 18, 2024
Morgan Gonzales

Medication-based treatment is the gold standard for treating opioid use disorder (OUD) – yet patients often struggle to access it.

Some people seeking buprenorphine, one type of MOUD, turn to diverted medications, which are prescriptions not originally intended for that person.

New research shows that almost half of patients who enter virtual OUD treatment were already taking buprenorphine – and that nearly 40% of those patients obtained buprenorphine not prescribed for them. That’s according to a new study published in Substance Use & Misuse, authored by researchers affiliated with OUD treatment provider Bicycle Health.

“When you talk about expanding access to medications for OUD like buprenorphine, the question of diversion always comes up,” Dr. Brian Clear, chief medical officer of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Provider
U.S. health care spending hits $4.9 trillion in 2023
National Health Expenditures In 2023: Faster Growth As Insurance Coverage And Utilization Increased
National Healthcare Spending in the U.S. Was Nearly $5 Trillion (with a “T”) in 2023 – New Data from CMS
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
The top 134 hospitals of 2024, according to Leapfrog

Share This Article